Abstract: Journal of Medical Physics and Biophysics Simulations

Abstract:
Radioiodine therapy is crucial for treating thyroid disorders, specifically thyroid cancer. This study aims to evaluate the efficacy of 30mCi and 50mCi radioiodine therapy doses in low-risk papillary thyroid carcino ma patient’s post-thyroidectomy, based on their thyroglobulin levels. In order to achieve this goal, we have carefully analyzed and evaluated the thy Ro globulin levels before and after radioiodine treatment, while also examining the values from different viewpoints. In our thorough analysis, we found that about 90% of study participants experienced positive outcomes, indicating a high success rate. The study shows that both radio iodine therapy doses effectively reduced thyroglobulin levels in low-risk papillary thyroid carcinoma patients post-thyroidectomy. This provides insights into the optimal therapy dosage for this patient group.